These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10940186)

  • 41. Sildenafil and erectile dysfunction.
    Lare SB; Labbate LA
    Am J Psychiatry; 2000 Dec; 157(12):2055-6. PubMed ID: 11097980
    [No Abstract]   [Full Text] [Related]  

  • 42. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipsychotic medications, psychological side effects and treatment engagement.
    Jones N
    Issues Ment Health Nurs; 2012 Jul; 33(7):492-3. PubMed ID: 22757602
    [No Abstract]   [Full Text] [Related]  

  • 44. Exacerbation of psychotic disorder during pregnancy in the context of medication discontinuation.
    Wakil L; Perea E; Penaskovic K; Stuebe A; Meltzer-Brody S
    Psychosomatics; 2013; 54(3):290-3. PubMed ID: 23218063
    [No Abstract]   [Full Text] [Related]  

  • 45. Limb malformations following maternal use of haloperidol.
    McCullar FW; Heggeness L
    JAMA; 1975 Jan; 231(1):62-4. PubMed ID: 1243570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison.
    Crespo-Facorro B; Pérez-Iglesias R; Mata I; Ramirez-Bonilla M; Martínez-Garcia O; Pardo-Garcia G; Caseiro O; Pelayo-Terán JM; Vázquez-Barquero JL
    J Psychopharmacol; 2011 Jun; 25(6):744-54. PubMed ID: 21292922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD
    Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depression and pregnancy.
    Varkukla M; Viguera AC; Gonsalves L
    Compr Ther; 2009; 35(1):44-9. PubMed ID: 19351104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroleptic-induced catatonia in two hospitalized patients.
    Gugger JJ; Saad M; Smith C
    J Pharm Pract; 2012 Apr; 25(2):250-4. PubMed ID: 22048928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychotic patients who become worse on neuroleptics.
    Bowers MB; Swigar ME
    J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of haloperidol neurotoxicity in acute hyperthyroidism: report of a case.
    Chu H; Lin JC; Hsu YD
    Acta Neurol Taiwan; 2004 Sep; 13(3):126-30. PubMed ID: 15508939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypothyroidism, psychotropic drugs and cardiotoxicity.
    Gomez J; Scott G
    Br J Psychiatry; 1980 Jan; 136():89-91. PubMed ID: 6101981
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano R; O'Gorman C; Harrigan RH
    Pharmacotherapy; 2010 Feb; 30(2):127-35. PubMed ID: 20099987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clozapine and dopamine.
    Aschheim E; Aschheim L
    Can J Psychiatry; 1997 Mar; 42(2):212. PubMed ID: 9067075
    [No Abstract]   [Full Text] [Related]  

  • 56. [In process].
    Stiefelhagen P
    Med Monatsschr Pharm; 2016 Sep; 39(9):398-9. PubMed ID: 29956516
    [No Abstract]   [Full Text] [Related]  

  • 57. [Mood disorders in pregnancy and post partum period].
    Dorsch VM; Rohde A
    MMW Fortschr Med; 2010 Dec; 152(48):27-30. PubMed ID: 21222331
    [No Abstract]   [Full Text] [Related]  

  • 58. Mirtazapine for neuroleptic-induced akathisia.
    Poyurovsky M; Weizman A
    Am J Psychiatry; 2001 May; 158(5):819. PubMed ID: 11329417
    [No Abstract]   [Full Text] [Related]  

  • 59. Olanzapine and tardive dyskinesia.
    Woods SW
    Br J Psychiatry; 1999 Oct; 175():391-2. PubMed ID: 10789313
    [No Abstract]   [Full Text] [Related]  

  • 60. [Neuroleptic malignant syndrome].
    Bryois C; Bondolfi G
    Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.